Andexanet alfa versus prothrombin complex concentrates/blood products as apixaban/rivaroxaban reversal agents: a survey among pediatric hematologists - Rodriguez, V; Stanek, J; Kerlin, B A; Dunn, A L (2022)
;28:10760296221078842